Restricted vs liberal intravenous fluid administration in preterm newborns less than 1 Kilogram
Phase 4
Not yet recruiting
- Conditions
- Health Condition 1: P84- Other problems with newborn
- Registration Number
- CTRI/2024/04/066302
- Lead Sponsor
- Dr Anitha Haribalakrishna
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All extremely low birth weight neonates less than 1000
grams
Exclusion Criteria
Neonates with major congenital anomaly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method all cause mortality <br/ ><br>Timepoint: 4 weeks <br/ ><br>
- Secondary Outcome Measures
Name Time Method eonatal morbiditiesTimepoint: During NICU stay or at discharge
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie fluid restriction benefits in ELBW neonates with P84 conditions?
How does restricted IV fluid compare to standard-of-care in ELBW neonates' renal function outcomes?
Which biomarkers correlate with optimal fluid management in preterm newborns under 1 kg with P84?
What adverse events are associated with liberal vs restricted fluid regimens in ELBW infants?
Are there combination therapies enhancing fluid restriction efficacy in ELBW neonates with P84?